These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 18160978

  • 1. Treatment of helminth co-infection in individuals with HIV-1: A systematic review of the literature.
    Walson JL, John-Stewart G.
    PLoS Negl Trop Dis; 2007 Dec 19; 1(3):e102. PubMed ID: 18160978
    [Abstract] [Full Text] [Related]

  • 2. Treatment of helminth co-infection in HIV-1 infected individuals in resource-limited settings.
    Walson JL, John-Stewart G.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD006419. PubMed ID: 18254104
    [Abstract] [Full Text] [Related]

  • 3. Deworming helminth co-infected individuals for delaying HIV disease progression.
    Walson JL, Herrin BR, John-Stewart G.
    Cochrane Database Syst Rev; 2009 Jul 08; (3):CD006419. PubMed ID: 19588389
    [Abstract] [Full Text] [Related]

  • 4. Antihelminthics in helminth-endemic areas: effects on HIV disease progression.
    Means AR, Burns P, Sinclair D, Walson JL.
    Cochrane Database Syst Rev; 2016 Apr 14; 4(4):CD006419. PubMed ID: 27075622
    [Abstract] [Full Text] [Related]

  • 5. Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.
    Walson JL, Otieno PA, Mbuchi M, Richardson BA, Lohman-Payne B, Macharia SW, Overbaugh J, Berkley J, Sanders EJ, Chung MH, John-Stewart GC.
    AIDS; 2008 Aug 20; 22(13):1601-9. PubMed ID: 18670219
    [Abstract] [Full Text] [Related]

  • 6. Species-specific treatment effects of helminth/HIV-1 co-infection: a systematic review and meta-analysis.
    Sangaré LR, Herrin BR, John-Stewart G, Walson JL.
    Parasitology; 2011 Oct 20; 138(12):1546-58. PubMed ID: 21729353
    [Abstract] [Full Text] [Related]

  • 7. Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.
    Pai NP, Lawrence J, Reingold AL, Tulsky JP.
    Cochrane Database Syst Rev; 2006 Jul 19; 2006(3):CD006148. PubMed ID: 16856117
    [Abstract] [Full Text] [Related]

  • 8. Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults.
    Modjarrad K, Zulu I, Redden DT, Njobvu L, Lane HC, Bentwich Z, Vermund SH.
    J Infect Dis; 2005 Oct 01; 192(7):1277-83. PubMed ID: 16136473
    [Abstract] [Full Text] [Related]

  • 9. Associations between helminth infection and CD4+ T cell count, viral load and cytokine responses in HIV-1-infected Ugandan adults.
    Elliott AM, Mawa PA, Joseph S, Namujju PB, Kizza M, Nakiyingi JS, Watera C, Dunne DW, Whitworth JA.
    Trans R Soc Trop Med Hyg; 2003 Oct 01; 97(1):103-8. PubMed ID: 12886815
    [Abstract] [Full Text] [Related]

  • 10. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi-site, randomised trial.
    Walson J, Singa B, Sangaré L, Naulikha J, Piper B, Richardson B, Otieno PA, Mbogo LW, Berkley JA, John-Stewart G.
    Lancet Infect Dis; 2012 Dec 01; 12(12):925-32. PubMed ID: 22971323
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of intestinal worms is associated with decreased HIV plasma viral load.
    Wolday D, Mayaan S, Mariam ZG, Berhe N, Seboxa T, Britton S, Galai N, Landay A, Bentwich Z.
    J Acquir Immune Defic Syndr; 2002 Sep 01; 31(1):56-62. PubMed ID: 12352151
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
    Mbuagbaw L, Mursleen S, Irlam JH, Spaulding AB, Rutherford GW, Siegfried N.
    Cochrane Database Syst Rev; 2016 Dec 10; 12(12):CD004246. PubMed ID: 27943261
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
    Siegfried N, Uthman OA, Rutherford GW.
    Cochrane Database Syst Rev; 2010 Mar 17; 2010(3):CD008272. PubMed ID: 20238364
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS, Dokubo EK, Sint TT.
    Cochrane Database Syst Rev; 2010 Mar 17; (3):CD008440. PubMed ID: 20238370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.